Heparin Fallout Likely To Impact Supplement Ingredient Testing Exemptions
This article was originally published in The Tan Sheet
Executive Summary
The discovery of adulterated ingredients in imported prescription drugs will likely cause increased scrutiny of supply chain operations for other segments across the food and drug industries
You may also be interested in...
US FDA Requests Ranitidine Removals
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.
US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.
FDA Finds Morphine-Spiked Herbal Cough Syrup In Chinese Firm's Plant
The finding of morphine in a consumer health product made in China could rekindle concerns about lapses in supply chain security previously linked to drugs and adulterants or contaminants found in other imported FDA-regulated products.